Definium Therapeutics issues options for 30,330 shares to new hires under inducement plan
DFTX•Inducement stock options granted to two new employees
Definium Therapeutics issued inducement stock options covering 30,330 common shares to two newly hired non-executive employees.
- The options carry an effective grant date of July 20, 2026.
- The exercise price is set at the closing price of Definium’s common shares on the grant date.
- The award vests over four years: 25% after year one, with the remainder vesting in monthly installments over the next three years.
